Abbildung 13: Perindopril - Bradykinin
The long term treatment of patients with coronary artery disease, with perindopril 8 mg once daily, significantly decreases serum ACE activities (p < 0.01) and increases plasma bradykinin concentrations (p < 0.05). These results provide the first evidence that long-term treatment with perindopril exerts anti ischemic effects on the myocardial ishemia induced by increased myocardial oxygen demand in patients with.